Effects and Interferences of Emicizumab, a Humanised Bispecific Antibody Mimicking Activated Factor VIII Cofactor Function, on Coagulation Assays

Thrombosis and Haemostasis - Germany
doi 10.1055/s-0039-1688687
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Management of Coagulation Factor VIII (FVIII) Inhibitors

Thrombosis Research
Hematology
2019English

Effects of Factor Xa and Protein S on the Individual Activated Protein C-Mediated Cleavages of Coagulation Factor Va

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2006English

Covalent Immobilization of Coagulation Factor VIII on Magnetic Nanoparticles for Aptamer Development

Journal of Applied Biomaterials and Functional Materials
MedicineBioengineeringBiomaterialsBiomedical EngineeringBiophysics
2018English

Studies on the Procurement of Blood Coagulation Factor VIII: Effects of Plasma Freezing Rate and Storage Conditions on Cryoprecipitate Quality.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1985English

Elevated Coagulation Factor VIII Plasma Activity in a Patient With Lymphangiosarcoma

Internal Medicine
Internal MedicineMedicine
2012English

Cloning of a cDNA Coding for Human Factor V, a Blood Coagulation Factor Homologous to Factor VIII and Ceruloplasmin.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1986English

Interferences From Blood Collection Tube Components on Clinical Chemistry Assays

Biochemia Medica
2014English

The Anticoagulant Function of Coagulation Factor V

Thrombosis and Haemostasis
Hematology
2012English

Factor VIII Arg2304 → His Binds to Phosphatidylserine and Is a Functional Cofactor in the Factor X-Ase Complex

Thrombosis and Haemostasis
Hematology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy